Vistagen Therapeutics Inc (VTGN)

Finanzdaten der Vistagen Therapeutics Inc-Aktie (VTGN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	217.42%1.48	0.47	0.30	0.26	0.24
	13.72%14.82	17.18	19.85	20.31	16.05
Research and Development	16.49%10.91	13.06	14.22	15.92	11.68
Operating Income/Loss	20.15%-13.35	-16.72	-19.55	-20.05	-15.80
Income/Loss From Continuing Operations Before Tax	19.90%-13.03	-16.27	-18.90	-19.42	-15.10
Income Tax Expense/Benefit	100.00%-	0.01	-	-	-
	19.93%-13.03	-16.27	-18.90	-19.42	-15.10
Attributable To Parent	19.93%-13.03	-16.27	-18.90	-19.42	-15.10
Basic Average Shares	42.98	-	42.23	35.75	31.93
Diluted Average Shares	42.98	-	42.23	35.75	31.93
Basic Earnings Per Share	-0.30	-	-0.45	-0.54	-0.47
Diluted Earnings Per Share	-0.30	-	-0.45	-0.54	-0.47